'Noncorporate' feel for Novartis property in Cambridge

How will Novartis' ($NVS) new facility in Cambridge, MA, change the landscape? Check out the Boston Globe's look at concepts from Vietnam Veterans Memorial architect Maya Lin and other prominent designers. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.